Wang Y, Wang Y, Xu P
Front Pharmacol. 2024; 15:1453034.
PMID: 39263573
PMC: 11387167.
DOI: 10.3389/fphar.2024.1453034.
Matama T, Costa C, Fernandes B, Araujo R, Cruz C, Tortosa F
J Adv Res. 2023; 64:45-65.
PMID: 37967812
PMC: 11464751.
DOI: 10.1016/j.jare.2023.11.013.
Alanazi A, Alsalhi W, Alghuyaythat W, Almutairi A, Almazrou M, Alabdulminaim J
Cureus. 2023; 15(10):e46517.
PMID: 37927722
PMC: 10625171.
DOI: 10.7759/cureus.46517.
Al Rajaibi R, Al Saadi B
Oman Med J. 2023; 38(2):e491.
PMID: 37132003
PMC: 10148980.
DOI: 10.5001/omj.2023.15.
Villani A, Ferrillo M, Fabbrocini G, Ocampo-Garza S, Scalvenzi M, Ruggiero A
Int J Trichology. 2023; 14(6):191-196.
PMID: 37034552
PMC: 10075351.
DOI: 10.4103/ijt.ijt_90_21.
Characteristics of Patients with Hair Loss after Isotretinoin Treatment: A Retrospective Review Study.
Tran P, Evron E, Goh C
Int J Trichology. 2022; 14(4):125-127.
PMID: 36081443
PMC: 9447463.
DOI: 10.4103/ijt.ijt_80_20.
Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication.
Monari P, Gualdi G, Bettoni G, Costa R, Ragni G, Zani F
J Clin Med. 2022; 11(5).
PMID: 35268325
PMC: 8911426.
DOI: 10.3390/jcm11051234.
Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review.
Lytvyn Y, McDonald K, Mufti A, Beecker J
JAAD Int. 2022; 6:125-142.
PMID: 35199047
PMC: 8841364.
DOI: 10.1016/j.jdin.2022.01.002.
Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
Babaei K, Kavoussi H, Rezaei M, Kavoussi R
An Bras Dermatol. 2021; 96(6):688-692.
PMID: 34593265
PMC: 8440166.
DOI: 10.1016/j.abd.2021.05.006.
Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder.
Zhang Y, Xu X, Zhang K
J Clin Psychopharmacol. 2021; 41(5):605-606.
PMID: 34369904
PMC: 8407445.
DOI: 10.1097/JCP.0000000000001454.
Telogen Effluvium: A Review of the Literature.
Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R
Cureus. 2020; 12(5):e8320.
PMID: 32607303
PMC: 7320655.
DOI: 10.7759/cureus.8320.
Curling of Hair in Two Female Patients Taking Alitretinoin.
Alting K, van Hunsel F
Drug Saf Case Rep. 2018; 5(1):26.
PMID: 30327960
PMC: 6191403.
DOI: 10.1007/s40800-018-0092-1.
Unusual and Interesting Adverse Cutaneous Drug Reactions.
Masatkar V, Nagure A, Gupta L
Indian J Dermatol. 2018; 63(2):107-116.
PMID: 29692451
PMC: 5903039.
DOI: 10.4103/ijd.IJD_584_17.
Autophagy is essential for maintaining the growth of a human (mini-)organ: Evidence from scalp hair follicle organ culture.
Parodi C, Hardman J, Allavena G, Marotta R, Catelani T, Bertolini M
PLoS Biol. 2018; 16(3):e2002864.
PMID: 29590104
PMC: 5891029.
DOI: 10.1371/journal.pbio.2002864.
Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
Chartier M, Morency L, Zylber M, Najmanovich R
BMC Pharmacol Toxicol. 2017; 18(1):18.
PMID: 28449705
PMC: 5408384.
DOI: 10.1186/s40360-017-0128-7.
[Development of curly hair under systemic therapy with alitretinoin].
Herink C, Schon M, Mossner R
Hautarzt. 2015; 66(8):617-9.
PMID: 25633723
DOI: 10.1007/s00105-015-3579-z.
Body image dissatisfaction in patients with inflammatory bowel disease.
Saha S, Zhao Y, Shah S, Esposti S, Lidofsky S, Shapiro J
Inflamm Bowel Dis. 2015; 21(2):345-52.
PMID: 25569736
PMC: 4373552.
DOI: 10.1097/MIB.0000000000000270.
Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer.
Park J, Kim J, Yun S, Kim H, Ihm C
Ann Dermatol. 2014; 26(6):743-6.
PMID: 25473228
PMC: 4252673.
DOI: 10.5021/ad.2014.26.6.743.
Excess granulation tissue and hair loss following acitretin.
Gaudiello F, Scalvenzi M, Gallo L, Balato N
Dermatol Reports. 2014; 3(1):e2.
PMID: 25386257
PMC: 4211490.
DOI: 10.4081/dr.2011.e2.
Madarosis: a marker of many maladies.
Kumar A, Karthikeyan K
Int J Trichology. 2012; 4(1):3-18.
PMID: 22628984
PMC: 3358936.
DOI: 10.4103/0974-7753.96079.